12 April 2016 - Data from past clinical trials can be used to draw new conclusions about diseases and treatments long after a trial is over.

But researchers rarely take advantage of this valuable resource even though access to a full data set, rather than published results alone, can help further research on how certain groups of people respond to a treatment or how people with an illness fare over time. In some cases, revisiting clinical trial data can also reveal problems with the initial analysis.

For more details, go to: http://www.nytimes.com/2016/04/12/opinion/making-the-most-of-clinical-trial-data.html?emc=edit_th_20160412&nl=todaysheadlines&nlid=20088616&_r=0